Extracellular vesicles (EVs) appear as important actors in cell-to-cell communication. EV content is characterized by proteins and RNA species that dynamically reflect cell and tissue state. Urinary EVs in particular may act in inter-nephron communication with possible beneficial or detrimental effects. Increasing interest is addressed to the pharmacological properties of EVs as a cell-free therapy, since several of the effects crAQ/tgqcedited to stem cells have been recapitulated by administration of their EVs. Preclinical data in models of renal damage indicate a general regenerative potential of EVs derived from mesenchymal stromal cells of different sources, including bone marrow, fetal tissues, urine and kidney. In this review we will discuss the results on the effect of EVs in repair of acute and chronic renal injury, and the mechanisms involved. In addition, we will analyse the strategies for EV pharmacological applications in renal regenerative medicine and limits and benefits involved.

Extracellular vesicles in renal tissue damage and regeneration

BRUNO, Stefania
First
;
PORTA, STEFANO;BUSSOLATI, Benedetta
Last
2016-01-01

Abstract

Extracellular vesicles (EVs) appear as important actors in cell-to-cell communication. EV content is characterized by proteins and RNA species that dynamically reflect cell and tissue state. Urinary EVs in particular may act in inter-nephron communication with possible beneficial or detrimental effects. Increasing interest is addressed to the pharmacological properties of EVs as a cell-free therapy, since several of the effects crAQ/tgqcedited to stem cells have been recapitulated by administration of their EVs. Preclinical data in models of renal damage indicate a general regenerative potential of EVs derived from mesenchymal stromal cells of different sources, including bone marrow, fetal tissues, urine and kidney. In this review we will discuss the results on the effect of EVs in repair of acute and chronic renal injury, and the mechanisms involved. In addition, we will analyse the strategies for EV pharmacological applications in renal regenerative medicine and limits and benefits involved.
2016
790
83
91
www.elsevier.com/locate/ejphar
Acute kidney injury; Cell-free therapy; Exosomes; Mesenchymal stem cells; MicroRNA; Animals; Cell Communication; Cell- and Tissue-Based Therapy; Extracellular Vesicles; Humans; Kidney; Regeneration; Pharmacology
Bruno, Stefania; Porta, Stefano; Bussolati, Benedetta
File in questo prodotto:
File Dimensione Formato  
porta et al..pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 631.67 kB
Formato Adobe PDF
631.67 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1633237
Citazioni
  • ???jsp.display-item.citation.pmc??? 43
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 54
social impact